Vitrafy Life Sciences Limited has released a press release.
FY26 Half Year Results Presentation
Filed with ASX ·
6ix hasn’t read this filing yet.
Vitrafy Life Sciences Ltd. on 6ix
In the deck
Story so far
Earlier from Vitrafy Life Sciences
- Q2 FY26 Quarterly Activities Report and Appendix 4C
- Vitrafy Enters Strategic Commercial Agreement with IMV
- IMV Strategic Partnership Investor Presentation
- Q1 FY26 Quarterly Activities Report and Appendix 4C
- FY25 Full Year Results Presentation - Amended
Later from Vitrafy Life Sciences
- USAISR Completes Phase 2 Platelet Study
- Q3 FY26 Quarterly Activities Report and Appendix 4C
- Final US Army Phase 2 Platelet Results
- Phase 2 USAISR Platelet Results Investor Presentation
- Vitrafy enters a partnership with Vitalant Innovation Center
Follow Vitrafy Life Sciences into a list and get an email when it puts out news.
Follow Vitrafy Life Sciences